A groundbreaking study has identified specific changes in the human microbiome that are associated with cognitive decline in Parkinson's disease, offering new insights into how bacteria living in the mouth and gut might contribute to the progression of this neurodegenerative disorder.
The research, published June 9 in the journal Gut Microbes, found that harmful bacteria migrating from the mouth to the gut was tied to Parkinson's patients shifting from mild memory issues to full-blown dementia. The study analyzed gut and mouth bacteria among 114 people, including 41 Parkinson's patients with mild cognitive impairment and 47 Parkinson's patients with dementia.
Bacterial Migration Drives Cognitive Decline
Researchers discovered clear differences in the types and functions of bacteria between the groups. In people with cognitive impairment, the gut contained more harmful bacteria, including many strains that likely migrated there from the mouth. These bacteria were found to produce toxins that can damage gut tissue, promote inflammation and possibly affect the brain.
"We don't yet know if the bacteria are causing the cognitive decline or if changes in the body due to Parkinson's allow these bacteria to grow, but our findings suggest they may play an active role in worsening symptoms," said lead researcher Frederick Clasen, a research associate at the Quantitative Systems Biology Lab at King's College London.
Gut-Brain Axis Connection
The findings add to growing evidence that the gut-brain axis plays a crucial role in neurodegenerative diseases. Senior researcher Saeed Shoaie, group leader of the Quantitative Systems Biology Lab at King's College London, explained that "disruptions in the gut-brain axis could trigger inflammation and immune responses that contribute to neuronal damage."
The research builds on previous work showing connections between gut bacteria and Parkinson's risk. An earlier study published in Parkinsonism & Related Disorders found that people who received five or more courses of penicillin within a five-year span had a 15% lower risk of Parkinson's compared with those who took no antibiotics, suggesting that antibiotic-induced changes to gut bacteria might influence disease risk.
Potential for Early Detection and Treatment
The bacterial toxins identified in the study could serve as biological markers to identify patients at higher risk of dementia in Parkinson's disease. "These toxins could be used as biological markers to identify patients at higher risk of dementia in Parkinson's," Clasen noted. "In the future, they might also be targets for new treatments that protect the brain by changing the gut environment."
Lifestyle Interventions Show Promise
The findings highlight the importance of healthy lifestyle behaviors for people with Parkinson's disease, particularly maintaining good oral hygiene and proper nutrition. As Shoaie explained, "As people with Parkinson's become increasingly reliant on [caregivers], routine practices such as oral hygiene and nutritional intake may be neglected."
The research suggests that promoting a healthy microbiome through consistent oral care, a balanced diet, and potentially targeted probiotic interventions could support improved disease management in Parkinson's patients.
Future Research Directions
The research team plans to investigate how these bacteria and toxins might affect brain function and whether lifestyle changes could help slow or prevent dementia in Parkinson's patients. The study represents a significant step forward in understanding the complex relationship between the microbiome and neurodegenerative disease progression, potentially opening new avenues for both prevention and treatment strategies.
